Clinical trial · Observational
Surveillance Imaging Modalities for Breast Cancer Assessment
Comparative Effectiveness of Surveillance Modalities in Breast Cancer Survivors
NCT02212834CI-TRIAL-00080081SIMBAcompletedResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine the effectiveness of surveillance breast MRI compared to mammography alone in women with a personal history of breast cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Mammograms
- description
- Surveillance mammograms in women with a personal history of breast cancer
- label
- Breast MRI
- description
- Surveillance breast Magnetic Resonance Imaging (MRI) in women with a personal history of breast cancer
Primary outcomes (1)
- measure
- Number of Breast Cancers Detected
- timeFrame
- 12 months post surveillance exam
- description
- Number of second breast cancers detected in the 12 months after surveillance mammogram or breast MRI
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Surveillance imaging exams in women included in the Breast Cancer Surveillance Consortium who are 18+ years of age at the the of a Stage 0-III incident breast cancer diagnosis between January 1, 2005 and December 31, 2012. \- Exclusion Criteria: * Women with a diagnosis of lobular carcinoma in situ * Women with missing cancer staging data from Surveillance, Epidemiology and End Results (SEER) Program records * Women with Stage 4 breast cancer at time of diagnosis * Women with a diagnosis of a second breast cancer event within six months of the primary diagnosis * Women who die within six months of primary diagnosis * Women who have had a double mastectomy
References
Publications (3)
- BACKGROUNDJohnson DS, Bush MT, Brandzel S, Wernli KJ. The patient voice in research-evolution of a role. Res Involv Engagem. 2016 Feb 22;2:6. doi: 10.1186/s40900-016-0020-4. eCollection 2016. PMID 29062507
- BACKGROUNDHenderson LM, Ichikawa L, Buist DSM, Lee JM, Bush M, Johnson D, Onega T, Nekhlyudov L, Kerlikowske K, Miglioretti DL, Sprague BL, Wernli KJ. Patterns of Breast Imaging Use Among Women with a Personal History of Breast Cancer. J Gen Intern Med. 2019 Oct;34(10):2098-2106. doi: 10.1007/s11606-019-05181-6. Epub 2019 Aug 13. PMID 31410813
- RESULTWernli KJ, Ichikawa L, Kerlikowske K, Buist DSM, Brandzel SD, Bush M, Johnson D, Henderson LM, Nekhlyudov L, Onega T, Sprague BL, Lee JM, Lehman CD, Miglioretti DL. Surveillance Breast MRI and Mammography: Comparison in Women with a Personal History of Breast Cancer. Radiology. 2019 Aug;292(2):311-318. doi: 10.1148/radiol.2019182475. Epub 2019 Jun 4. PMID 31161975